MicroPort Swoops In On Bankrupt Lombard Medical
Executive Summary
Chinese medtech group MicroPort Scientific has bagged another cardiology deal this year, this time buying up its UK aortic valve repair partner Lombard Medical, which has run aground after failing to navigate itself out of financial troubles.
You may also be interested in...
M&A Analysis: Volume Shrinks In April But Value Inflated By Big Acquisitions
Medtech M&A activity dipped in April from last month but brought in a number of high-value acquisitions. Highlights included Fresenius, the world's largest dialysis firm, selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15bn to investment firm Summit Partners.
Endologix Looks To COO For New Leadership And Business Turnaround
Endovascular aortic repair specialist Endologix has promoted its COO John Onopchenko to the role of chief executive. He succeeds John McDermott, who stepped down as CEO in February following a couple of challenging years for the company.
LivaNova On The Mend With Stronger, Sharper Focus
LivaNova has had a reboot and its new senior management team, including a new CEO, looks to be steering the $1.2bn cardio-neuro group towards growth. A more stringent focus on the cardiac surgery and neuromodulation businesses – boosted by strategic M&A tuck-ins – are expected to reap short-term wins, while calculated bets on multiple shots on goal will hopefully bring longer-term rewards. As he approaches his one-year anniversary at LivaNova, CEO Damien McDonald chats to Medtech Insight about his journey so far to unlocking the significant potential he believes the company holds.